It all depends on what happens after the R/S. IE if there is good news afterwards or a deal of some sort, it could be significantly higher. Even more so with successful test results.
In a straight R/S or S... the value of what you have should be the same afterwards. You just end up with Less or More shares (respectively).
Obviously with the R/S news... the stock price has taken a beating. R/S in many Penny scenarios isn't a good thing... in this situation, many are taking it as an opportunistic move. If the price keeps moving lower... the R/S move may be worthless.
Either way... weigh your risks. I don't think anyone can tell you for sure. I too am looking to POTENTIALLY add more shares. But it really depends on certain factors.
Their trials could also end up a bust and the stock could tank. This just happened to another bio/pharma recently.
News 
Market Data 
Discover 
